Carlos Martínez-Rivera

10PUBLICATIONS
37CO-AUTHORS
Occupational epidemiologyRespiratory diseasesDisease surveillanceInfant and child healthDecision making
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 27, 2025
ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit.

Carlos Martínez-Rivera, Marina Blanco-Aparicio, Francisco Casas-Maldonado

|Oct 28, 2025
Comorbidities as a Personalized Target in Patients with Severe Asthma Treated with Dupilumab.

Carlota Gonzalez-Lluch, Maria Basagaña, Laura Pardo

|Jul 25, 2025
The Impact of the Quality of Care for Adults with Acute Asthma in the Emergency Department of a Tertiary Hospital: A 1-Year Follow-Up Study.

Carlos Martinez Rivera, Agnes Hernandez Biette, Anna Núñez Condominas

|Dec 17, 2024
Prognostic Factors in Severe Eosinophilic Asthma in a Pediatric Population: A Prospective Cohort Study in Spain.

Clara Padró-Casas, María Basagaña, María Del Mar Martínez-Colls

|Nov 09, 2024
Comparison of the Determinants of the "Chronic Obstructive Pulmonary Disease Assessment Test" (CAT) and the "Asthma Control Test" (ACT) in Patients with Asthma-COPD Overlap.

Cristina Aljama, Galo Granados, Francisco Javier Callejas-González

|Feb 16, 2024
Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis.

Maria Basagaña, Carlos Martínez-Rivera, Clara Padró

Pageof 2

Frequent Collaborators

2 joint publications

Francisco Javier Callejas-González

2 joint publications

Francisco Casas-Maldonado

2 joint publications

Mimar Martínez-Colls

2 joint publications

Marc Miravitlles